Loading…
Loading…
Merck & Co Inc
NYSE · Stock Profile · Market Cap $284.19B
Current Price
$114.50
-1.18%GoodMoat Value
$121.09
5.8% undervaluedNet income compounded at 22.3% annually over 6 years.
Forward estimates use 16.9% FCF growth (CAGR)
Net Debt: 34.8B
16.1B
FY24
16.7B
FY24
64.2B
FY24
15.5B
FY25
15.8B
FY25
17.3B
FY25
65.0B
FY25
5.5B
FY24
3.2B
FY24
17.1B
FY24
5.1B
FY25
4.4B
FY25
5.8B
FY25
18.3B
FY25
At Merck, known as MSD outside of the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have brought hope to humanity through the development of important medicines and vaccines. We aspire to be the premier research-intensive biopharmaceutical company in the world – and today, we are at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals. We foster a diverse and inclusive global workforce and operate responsibly every day to enable a safe, sustainable, and healthy future for all people and communities.
Sector
Healthcare
Industry
Drug Manufacturers - General
Exchange
NYSE
Country
New Jersey, USA
MRK's revenue grew at a 26.2% CAGR over the last 6 years.
Blended fair value estimate based on DCF, Graham Number, and earnings-based models.
Run a full DCF analysis with customizable assumptions
Open DCF Calculator →Graham Number, PEG-based, and Earnings-based models
View Fair Value →Dividend Yield
2.85%
At Merck, known as MSD outside of the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have brought hope to humanity through the development of important medicines and vaccines. We aspire to be the premier research-intensive biopharmaceutical company in the world – and today, we are at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals. We foster a diverse and inclusive global workforce and operate responsibly every day to enable a safe, sustainable, and healthy future for all people and communities.
Sector
Healthcare
Industry
Drug Manufacturers - General
Exchange
NYSE
Country
New Jersey, USA